DOCSLIB.ORG

Difference from Preconditioning in the Role of Protein Kinase C

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Difference from Preconditioning in the Role of Protein Kinase C View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector JACC Vol. 29, No. 3 693 March 1, 1997:693–701 Infarct Size Limitation by a New Na1-H1 Exchange Inhibitor, Hoe 642: Difference From Preconditioning in the Role of Protein Kinase C TETSUJI MIURA, MD, PHD, TAKASHI OGAWA, MD, KATSUO SUZUKI, MD, MAHIKO GOTO, MD, KAZUAKI SHIMAMOTO, MD, PHD Sapporo, Japan Objectives. This study examined the effect of a new specific Results. In pentobarbital-anesthetized rabbits, 0.3 mg/kg and Na1-H1 exchange inhibitor, Hoe 642, on infarct size and the 0.6 mg/kg of Hoe 642 given before ischemia limited infarct size (as protective role of protein kinase C (PKC) by this agent. In percent area at risk [%IS/AR]) to 42.7 6 4.4% (SEM) and 26.2 6 addition, we assessed the possible alteration of Hoe 642–induced 5.4%, respectively, from the control value of 55.1 6 3.5%. However, cardioprotection by commonly used animal anesthetic drugs. injection of Hoe 642 before reperfusion did not change infarct size Background. Earlier studies on the contribution of Na1-H1 (%IS/AR 49.6 6 4.9%, p 5 0.387; power 0.81 for detecting 50% exchange to ischemic injury were complicated by nonspecific reduction). Infarct size limitation by the preischemic treatment actions of the Na1-H1 exchange inhibitors, and the role of this with Hoe 642 was similarly observed in the rabbits anesthetized exchanger in myocardial infarction in vivo remains unclear. The with ketamine/xylazine. In the polyB-treated rabbits, 0.6 mg/kg of difference in anesthetic agents used in experiments could have Hoe 642 significantly limited infarct size (%IS/AR was 28.3 6 3.8% resulted in discrepant findings regarding cardioprotection of with Hoe 642 and 50.1 6 7.5% without Hoe 642), although some interventions, such as preconditioning and adenosine preconditioning was blocked by the same dose of polyB (%IS/AR triphosphate–sensitive potassium channel openers. was 39.3 6 6.1% with polyB and 11.3 6 2.4% without polyB). Methods. Infarction was induced by 30 min of coronary occlu- Conclusions. Hoe 642 enhanced myocardial tolerance against sion and3hofreperfusion in the rabbit heart. In the first series infarction, and this enhanced tolerance was not influenced by of experiments, rabbits were anesthetized with pentobarbital or anesthetic agents commonly used for infarct size studies. Infarct ketamine/xylazine. Hoe 642 was injected intravenously 10 min size limitation by Hoe 642 was not inhibited by polyB, suggesting before ischemia or 5 min before reperfusion. In the second series that cardioprotection by Na1-H1 exchange inhibition is not PKC of experiments, rabbits received 25 mg/kg body weight of poly- mediated and thus may be unrelated to preconditioning. myxin B (polyB), Hoe 642 plus polyB, preconditioning with 5 min (J Am Coll Cardiol 1997;29:693–701) of ischemia and 5 min of reperfusion plus polyB or precondition- q1997 by the American College of Cardiology ing alone before 30 min of ischemia. In animal models of myocardial infarction, it has been well a toxic level (i.e., “Ca21 overload”) has been suggested to be established that infarct size after coronary artery occlusion is critical for transition from reversible to irreversible injury (6), determined mainly by three factors: the size of ischemic it is still unclear how a Ca21 overload is induced in ischemic myocardial mass, the level of residual blood flow in the cardiomyocytes. A possible mechanism, which recently re- ischemic region (i.e., coronary collateral blood flow) and the ceived much attention, is increased Ca21 entry through the duration of the coronary occlusion (1,2). Clinical findings also Na1-Ca21 exchange, secondary to the accumulation of Na1 in show that these factors critically influence the size of infarct, the myocytes (7,8). The intracellular Na1 level rapidly in- and thus the outcome in patients with acute myocardial creases after the onset of ischemia, to which the extrusion of infarction (3–5). However, the cellular mechanism of ischemic H1 by Na1-H1 exchange, decreased Na1 efflux by Na1-K1 myocyte death is not clearly understood. Although an elevation pump and Na1 influx through Na1 channels may be contrib- of the cytosolic free Ca21 level in myocytes during ischemia to utory. If an intracellular Na1 buildup does indeed trigger the Ca21 overload during ischemia, inhibition of the Na1-H1 exchange would attenuate ischemic myocardial injury. This From the Second Department of Internal Medicine, Sapporo Medical hypothesis was supported by the recent findings that Na1-H1 University School of Medicine, Sapporo, Japan. This study was supported in part exchange inhibitors suppressed the elevation of intracellular by Grant-in-Aid for Scientific Research 90199951 from the Ministry of Educa- 1 tion, Science and Culture, Tokyo, Japan. Na during ischemia and improved the postischemic contrac- Manuscript received July 16, 1996; revised manuscript received October 25, tile function in isolated whole hearts and papillary muscle 1996, accepted November 5, 1996. preparations (8–16). However, the agents used in earlier Address for correspondence: Dr. Tetsuji Miura, Second Department of 1 1 Internal Medicine, Sapporo Medical University School of Medicine, South-1, studies for inhibiting Na -H exchange (i.e., amiloride and its West-16, Chuo-ku, Sapporo, 060 Japan. E-mail: [email protected]. derivatives) are not necessarily specific to this antiporter, and q1997 by the American College of Cardiology 0735-1097/97/$17.00 Published by Elsevier Science Inc. PII S0735-1097(96)00522-0 694 MIURA ET AL. JACC Vol. 29, No. 3 INFARCT SIZE LIMITATION BY HOE 642 March 1, 1997:693–701 istration of this agent before ischemia and that before reper- Abbreviations and Acronyms fusion was examined. In the second series of experiments, ANOVA 5 analysis of variance involvement of PKC in the cardioprotective mechanism of Hoe EIPA 5 ethylisopropyl amiloride 642 was examined by an inhibitor of PKC, polymyxin B %IS/AR 5 infarct size as percent area at risk (polyB). KATP 5 ATP-sensitive potassium channel MIA 5 methylisobutyl amiloride NHE-1 5 Na1-H1 exchange type 1 PC 5 preconditioned Methods PKC 5 protein kinase C This study conformed to the guidelines of Sapporo Medical polyB 5 polymyxin B University on animal usage. TTC 5 triphenyltetrazolium Experiment 1: Effect of Hoe 642 on Myocardial Infarct Size act on Na1-Ca21 exchange as well as Ca21 and Na1 channels Surgical preparation. Male albino rabbits (Japanese (17). white) weighing 2.1 to 2.5 kg were anesthetized with pentobar- Recently, infarct size limitation by a Na1-H1 exchange inhib- bital sodium in Protocol 1 or with ketamine/xylazine in Protocol itor was reported in swine models of infarction (18,19). However, 2. Pentobarbital sodium was administered as a slow bolus it remains unclear whether this protection is independent of injection of 40 mg/kg body weight, and an additional small experimental conditions, particularly in animal species and with bolus (;4 mg/kg) was given when necessary. A ketamine/ anesthetic agents. These problems are not negligible for assessing xylazine injection (a mixture of 10 mg/ml of ketamine and 5 the clinical applicability of Na1-H1 exchange inhibitors, and mg/ml of xylazine) was first given as a 1.0- to 1.5-ml bolus to actual differences in the infarct size-limiting effect with animal introduce anesthesia and was then continuously infused at species and anesthetic agents can be exemplified by adenosine ;0.06 to 0.10 ml/min to maintain anesthesia at a sufficient level trisphosphate–sensitive potassium channel (KATP) openers and to abolish the corneal reflex. The rabbit was tracheostomized ischemic preconditioning (20–25). In the experiments using pen- and ventilated with a Harvard rodent respirator using oxygen tobarbital, KATP openers protected the heart from infarction in supplement. The tidal volume was 15 ml, and the ventilation dogs (20) but not in rabbits (21). However, infarct size limitation rate and oxygen flow were adjusted to maintain arterial blood byaKATP opener was detected in the rabbit when ketamine/ gasses within the physiologic range. Fluid-filled catheters were xylazine was used as the anesthetic drug (24). In contrast, inserted into the carotid artery and jugular vein for monitoring preconditioning against infarction was more clearly observed in arterial pressure and infusing drugs, respectively. The chest pentobarbital-anesthetized rabbits compared with those anesthe- was opened through a left thoracotomy, the heart was exposed tized by ketamine/xylazine (23,25). and a 4-0 silk thread was passed around the marginal branch of Another intriguing question is the role of PKC in the the left circumflex coronary artery using a tapered needle. The mechanism of cardioprotection by Na1-H1 exchange inhibi- silk thread was threaded through a small vinyl tube to make a tors. Preconditioning with brief transient ischemia enhances coronary snare. Precordial electrocardiography was monitored myocardial resistance against infarction more than any phar- using bipolar leads corresponding to a CC5 lead. The rabbit macologic agent, and the involvement of PKC has been was then heparinized with 1,000 U of heparin, and 10 min was supported by a number of recent studies, including ours allowed for stabilization. According to the experimental pro- (26–29). Inhibition of Na1-H1 exchange would reduce Ca21 tocol (as outlined later), the coronary artery was occluded by entry through Na1-Ca21 exchange, which may suppress acti- the coronary snare for 30 min and then reperfused. After 3 h vation of calcium-dependent PKC. However, this does not of reperfusion, 2,000 U of heparin was intravenously adminis- necessarily exclude the possibility that inhibition of Na1-H1 tered, and the heart was excised and processed for postmortem might result in the enhanced production of a PKC-activating analysis of infarct.
Load more

Recommended publications
  • Molecular Mechanisms Underlying Ketamine-Mediated Inhibition Of
    Anesthesiology 2005; 102:93–101 © 2004 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Molecular Mechanisms Underlying Ketamine-mediated Inhibition of Sarcolemmal Adenosine Triphosphate- sensitive Potassium Channels Takashi Kawano, M.D.,* Shuzo Oshita, M.D.,† Akira Takahashi, M.D.,‡ Yasuo Tsutsumi, M.D.,* Katsuya Tanaka, M.D.,§ Yoshinobu Tomiyama, M.D.,࿣ Hiroshi Kitahata, M.D.,# Yutaka Nakaya, M.D.** Background: Ketamine inhibits adenosine triphosphate-sen- sensitive channel pore.3 These channels, as metabolic sitive potassium (KATP) channels, which results in the blocking sensors, are associated with such cellular functions as of ischemic preconditioning in the heart and inhibition of va- insulin secretion, cardiac preconditioning, vasodilata- sorelaxation induced by KATP channel openers. In the current 4–7 Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/102/1/93/357819/0000542-200501000-00017.pdf by guest on 27 September 2021 study, the authors investigated the molecular mechanisms of tion, and neuroprotection. ketamine’s actions on sarcolemmal KATP channels that are re- In cardiac myocytes, intravenous general anesthetics, associated by expressed subunits, inwardly rectifying potas- such as ketamine racemate, propofol, and thiamylal, di- sium channels (Kir6.1 or Kir6.2) and sulfonylurea receptors 8–10 rectly inhibit native sarcolemmal KATP channels. Al- (SUR1, SUR2A, or SUR2B). though these observations suggest that intravenous an- Methods: The authors used inside-out patch clamp configura- tions to investigate the effects of ketamine on the activities of esthetics may impair the endogenous organ protective reassociated Kir6.0/SUR channels containing wild-type, mutant, mechanisms mediated by KATP channels, the possibility or chimeric SURs expressed in COS-7 cells.
    [Show full text]
  • Biomol Average and SD Table S1.Xlsx
    Compound GliNS1 G179NS G166NS average, n=5 STD average, n=3 STD average, n=3 STD INTRACELLULAR CALCIUM Antibiotic A-23187 0.00 0.00 0.10 0.07 0.15 0.14 INTRACELLULAR CALCIUM Ryanodine 1.04 0.14 1.03 0.03 1.03 0.03 INTRACELLULAR CALCIUM Cyclopiazonic acid 1.01 0.06 0.88 0.05 0.92 0.06 INTRACELLULAR CALCIUM Gingerol 1.00 0.06 0.91 0.01 1.01 0.06 INTRACELLULAR CALCIUM Thapsigargin 0.00 0.01 0.00 0.00 0.10 0.12 INTRACELLULAR CALCIUM TMB-8 0.89 0.07 0.91 0.05 0.94 0.03 INTRACELLULAR CALCIUM Dantrolene 0.91 0.08 0.98 0.05 0.94 0.01 CALCIUM CHANNELS Amiloride 1.01 0.07 1.01 0.04 1.03 0.05 CALCIUM CHANNELS Benzamil 0.83 0.08 0.83 0.12 0.96 0.04 CALCIUM CHANNELS BAY K-8644 0.93 0.13 0.93 0.09 1.07 0.14 CALCIUM CHANNELS Diltiazem 0.96 0.07 0.99 0.12 0.94 0.14 CALCIUM CHANNELS L-cis-Diltiazem 0.91 0.17 1.01 0.12 0.95 0.12 CALCIUM CHANNELS Flunarizine 0.85 0.08 1.00 0.06 0.85 0.05 CALCIUM CHANNELS FPL-64176 0.99 0.11 0.95 0.07 1.05 0.05 CALCIUM CHANNELS Nifedipine 1.06 0.17 0.95 0.12 1.03 0.09 CALCIUM CHANNELS Nimodipine 1.05 0.06 0.95 0.03 1.06 0.17 CALCIUM CHANNELS Nitrendipine 0.99 0.07 0.96 0.10 1.04 0.09 CALCIUM CHANNELS SDZ-202791 R(-) 1.01 0.08 0.92 0.06 1.01 0.08 CALCIUM CHANNELS SKF-96365 0.73 0.05 0.70 0.11 0.69 0.04 CALCIUM CHANNELS Tetrandrine 0.47 0.07 0.76 0.16 0.87 0.20 CALCIUM CHANNELS Verapamil 1.01 0.02 0.89 0.07 1.06 0.20 CALCIUM CHANNELS Methoxy Verapamil 0.93 0.14 0.96 0.07 0.93 0.13 CALCIUM CHANNELS Bepridil 0.70 0.16 0.92 0.15 0.84 0.14 CALCIUM CHANNELS Amiodarone 0.32 0.12 0.58 0.07 0.48 0.23 CALCIUM CHANNELS YS035 1.00 0.16
    [Show full text]
  • The In¯Uence of Medication on Erectile Function
    International Journal of Impotence Research (1997) 9, 17±26 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 The in¯uence of medication on erectile function W Meinhardt1, RF Kropman2, P Vermeij3, AAB Lycklama aÁ Nijeholt4 and J Zwartendijk4 1Department of Urology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands; 2Department of Urology, Leyenburg Hospital, Leyweg 275, 2545 CH The Hague, The Netherlands; 3Pharmacy; and 4Department of Urology, Leiden University Hospital, P.O. Box 9600, 2300 RC Leiden, The Netherlands Keywords: impotence; side-effect; antipsychotic; antihypertensive; physiology; erectile function Introduction stopped their antihypertensive treatment over a ®ve year period, because of side-effects on sexual function.5 In the drug registration procedures sexual Several physiological mechanisms are involved in function is not a major issue. This means that erectile function. A negative in¯uence of prescrip- knowledge of the problem is mainly dependent on tion-drugs on these mechanisms will not always case reports and the lists from side effect registries.6±8 come to the attention of the clinician, whereas a Another way of looking at the problem is drug causing priapism will rarely escape the atten- combining available data on mechanisms of action tion. of drugs with the knowledge of the physiological When erectile function is in¯uenced in a negative mechanisms involved in erectile function. The way compensation may occur. For example, age- advantage of this approach is that remedies may related penile sensory disorders may be compen- evolve from it. sated for by extra stimulation.1 Diminished in¯ux of In this paper we will discuss the subject in the blood will lead to a slower onset of the erection, but following order: may be accepted.
    [Show full text]
  • Label-Free Cell Phenotypic Profiling Decodes the Composition And
    OPEN Label-free cell phenotypic profiling SUBJECT AREAS: decodes the composition and signaling POTASSIUM CHANNELS SENSORS AND PROBES of an endogenous ATP-sensitive Received potassium channel 28 January 2014 Haiyan Sun1*, Ying Wei1, Huayun Deng1, Qiaojie Xiong2{, Min Li2, Joydeep Lahiri1 & Ye Fang1 Accepted 24 April 2014 1Biochemical Technologies, Science and Technology Division, Corning Incorporated, Corning, NY 14831, United States of Published America, 2The Solomon H. Snyder Department of Neuroscience and High Throughput Biology Center, Johns Hopkins University 12 May 2014 School of Medicine, Baltimore, Maryland 21205, United States of America. Current technologies for studying ion channels are fundamentally limited because of their inability to Correspondence and functionally link ion channel activity to cellular pathways. Herein, we report the use of label-free cell requests for materials phenotypic profiling to decode the composition and signaling of an endogenous ATP-sensitive potassium should be addressed to ion channel (KATP) in HepG2C3A, a hepatocellular carcinoma cell line. Label-free cell phenotypic agonist Y.F. (fangy2@corning. profiling showed that pinacidil triggered characteristically similar dynamic mass redistribution (DMR) com) signals in A431, A549, HT29 and HepG2C3A, but not in HepG2 cells. Reverse transcriptase PCR, RNAi knockdown, and KATP blocker profiling showed that the pinacidil DMR is due to the activation of SUR2/ Kir6.2 KATP channels in HepG2C3A cells. Kinase inhibition and RNAi knockdown showed that the pinacidil * Current address: activated KATP channels trigger signaling through Rho kinase and Janus kinase-3, and cause actin remodeling. The results are the first demonstration of a label-free methodology to characterize the Biodesign Institute, composition and signaling of an endogenous ATP-sensitive potassium ion channel.
    [Show full text]
  • Thiruttu Tuomittur
    THIRUTTUUS009782416B2 TUOMITTUR (12 ) United States Patent ( 10 ) Patent No. : US 9 ,782 ,416 B2 Cowen (45 ) Date of Patent: Oct. 10 , 2017 ( 54 ) PHARMACEUTICAL FORMULATIONS OF 4 , 880 , 830 A 11/ 1989 Rhodes POTASSIUM ATP CHANNEL OPENERS AND 4 ,894 , 448 A 1 / 1990 Pelzer 5 ,063 , 208 A 11/ 1991 Rosenberg et al . USES THEREOF 5 , 284 ,845 A 2 / 1994 Paulsen 5 ,356 ,775 A 10 / 1994 Hebert et al . (71 ) Applicant: Essentialis , Inc. , Carlsbad , CA (US ) 5 ,376 , 384 A 12 / 1994 Eichel et al. 5 , 378 , 704 A 1 / 1995 Weller, III (72 ) Inventor: Neil Madison Cowen , Carlsbad , CA 5 , 399 , 359 A 3 / 1995 Baichwal 5 ,415 , 871 A 5 / 1995 Pankhania et al . (US ) 5 ,629 , 045 A 5 / 1997 Veech 5 , 733 , 563 A 3 / 1998 Fortier (73 ) Assignee : Essentialis , Inc. , Redwood City , CA 5 , 744 , 594 A 4 / 1998 Adelman et al . (US ) 5 , 965 ,620 A 10 / 1999 Sorgente et al . 6 ,022 , 562 A 2 /2000 Autant et al . 6 , 140 , 343 A 10 / 2000 Deninno et al . ( * ) Notice : Subject to any disclaimer , the term of this 6 , 146 ,662 A 11/ 2000 Jao et al . patent is extended or adjusted under 35 6 , 197, 765 B1 3 / 2001 Vardi et al. U . S . C . 154 (b ) by 0 days . 6, 197, 976 B1 3 / 2001 Harrington et al . 6 , 225, 310 B1 5 / 2001 Nielsen et al. (21 ) Appl. No. : 14 / 458 ,032 6 , 255 , 459 B1 7 / 2001 Lester et al . 6 , 277, 366 B1 8 / 2001 Goto et al .
    [Show full text]
  • Niflumic Acid Hyperpolarizes Smooth Muscle Cells Via Calcium-Activated Potassium Channel in Spiral Modiolar Artery of Guinea Pigs1
    Acta Pharmacol Sin 2008 Jul; 29 (7): 789–799 Full-length article Niflumic acid hyperpolarizes smooth muscle cells via calcium-activated potassium channel in spiral modiolar artery of guinea pigs1 Li LI2,3, Ke-tao MA3,4, Lei ZHAO3, Jun-qiang SI3,4,5, Zhong-shuang ZHANG3, He ZHU3, Jing LI3 2Departmeng of Pharmacology, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China; 3Labo- ratory of Xinjiang Endemic and Ethnic Diseases, Shihezi University Medical College, Xinjiang 832002, China; 4Fundamental Medical School of Wuhan University, Wuhan 430071, China Key words Abstract spiral modiolar artery; smooth muscle cells; Aim: The influence of niflumic acid (NFA), a Cl– channel antagonist, on the mem- 2+ niflumic acid; hyperpolarization; Ca - brane potentials in smooth muscle cells (SMC) of the cochlear spiral modiolar activated potassium channels; cochlea artery (SMA) in guinea pigs was examined. Methods: The intracellular recording 1This work was supported by the National and whole-cell recording technique were used to record the NFA-induced re- Natural Science Foundation of China (No sponse on the acutely-isolated SMA preparation. Results: The SMC had 2 stable 30460043); the Scientific and Technological Program for Overseas Personnel, the but mutually convertible levels of resting potentials (RP), that is, one was near –45 Ministry of Personnel, China (2006); and the mV and the other was approximately –75 mV, termed as low and high RP, Key Program of Scientific and Technological respectively. The bath application of NFA could cause a hyperpolarization in all Research, the Ministry of Education, China (Local Universities; No 207134). the low RP cells, but had little effect on high RP cells.
    [Show full text]
  • WO 2011/089216 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date t 28 July 2011 (28.07.2011) WO 2011/089216 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 47/48 (2006.01) C07K 1/13 (2006.01) kind of national protection available): AE, AG, AL, AM, C07K 1/1 07 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) Number: International Application DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/EP201 1/050821 HN, HR, HU, ID, J , IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 2 1 January 201 1 (21 .01 .201 1) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, (26) Publication Language: English TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 1015 1465. 1 22 January 2010 (22.01 .2010) EP kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, (71) Applicant (for all designated States except US): AS- ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, CENDIS PHARMA AS [DK/DK]; Tuborg Boulevard TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, 12, DK-2900 Hellerup (DK).
    [Show full text]
  • Inhibitory Mechanism of Nicorandil on Catecholamine Secretion from the Rat Adrenal Medulla
    2006년 2월 박사학위논문 Inhibitory Mechanism of Nicorandil on Catecholamine Secretion from the Rat Adrenal Medulla 조선대학교 대학원 의학과 이은숙 Inhibitory Mechanism of Nicorandil on Catecholamine Secretion from the Rat Adrenal Medulla 흰쥐 부신수질에서 니코란딜의 카테콜아민 분비작용에 대한 억제기전 2006년 2월 일 조선대학교 대학원 의학과 이은숙 Inhibitory Mechanism of Nicorandil on Catecholamine Secretion from the Rat Adrenal Medulla 지도교수 임임임 동동동 윤윤윤 이이이 논문을 의학박사 학위 신청논문으로 제출함. 2005 년 10 월 일 조조조선대학교조선대학교 대학원 의학과 이은숙 이 은 숙의 박사학위논문을 인준함 위원장 서울 대학교 교수 인인인 위위위 원원원 전남 대학교 교수 인인인 위위위 원원원 조선 대학교 교수 인인인 위위위 원원원 조선 대학교 교수 인인인 위위위 원원원 조선 대학교 교수 인인인 2005 년 12 월 29 일 조선대학교 대학원 CONTENTS KOREAN ABSTRACT ---------------------------------------------------------------------- I. INTRODUCTION ---------------------------------------------------------------------------- II. MATERIALS AND METHODS ----------------------------------------------------------- Experimental Procedure ------------------------------------------------------------------------------ Perfusion of Adrenal Gland -------------------------------------------------------------------------- Drug Administration --------------------------------- -------------------------------------------------- Collection of Perfusate -------------------------------------------------------------------------------- Measurement of Catecholamines ------------------------------------------------------------------ Statistical Analysis ------------------------------------------------------------------------------------- Drugs and Their Sources -----------------------------------------------------------------------------
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]
  • KATP Channel Openers Facilitate Glutamate Uptake by Gluts in Rat Primary Cultured Astrocytes
    Neuropsychopharmacology (2008) 33, 1336–1342 & 2008 Nature Publishing Group All rights reserved 0893-133X/08 $30.00 www.neuropsychopharmacology.org KATP Channel Openers Facilitate Glutamate Uptake by GluTs in Rat Primary Cultured Astrocytes 1,2 1,2 1 1 1 ,1 Xiu-Lan Sun , Xiao-Ning Zeng , Fang Zhou , Cui-Ping Dai , Jian-Hua Ding and Gang Hu* 1 Laboratory of Neuropharmacology, Department of Anatomy, Histology & Pharmacology, Nanjing Medical University, Nanjing, Jiangsu, P.R. China Increasing evidence, including from our laboratory, has revealed that opening of ATP sensitive potassium channels (KATP channels) plays the neuronal protective roles both in vivo and in vitro. Thus K channel openers (KCOs) have been proposed as potential ATP neuroprotectants. Our previous studies demonstrated that K channels could regulate glutamate uptake activity in PC12 cells as well as ATP in synaptosomes of rats. Since glutamate transporters (GluTs) of astrocytes play crucial roles in glutamate uptake and KATP channels are also expressed in astrocytes, the present study showed whether and how KATP channels regulated the function of GluTs in primary cultured astrocytes. The results showed that nonselective KCO pinacidil, selective mitochondrial KCO diazoxide, novel, and blood–brain barrier permeable KCO iptakalim could enhance glutamate uptake, except for the sarcolemmal KCO P1075. Moreover pinacidil, + diazoxide, and iptakalim reversed the inhibition of glutamate uptake induced by 1-methyl-4-phenylpyridinium (MPP ). These potentiated effects were completely abolished by mitochondrial K blocker 5-hydroxydecanoate. Furthermore, either diazoxide or iptakalim could ATP + inhibit MPP -induced elevation of reactive oxygen species (ROS) and phosphorylation of protein kinases C (PKC). These findings are the first to demonstrate that activation of KATP channel, especially mitochondrial KATP channel, improves the function of GluTs in astrocytes due to reducing ROS production and downregulating PKC phosphorylation.
    [Show full text]
  • Altered ATP-Sensitive Potassium Channels May Underscore Obesity-Trig- Gered Increase in Blood Pressure1
    Acta Pharmacol Sin 2008 Oct; 29 (10): 1167–1174 Full-length article Altered ATP-sensitive potassium channels may underscore obesity-trig- gered increase in blood pressure1 Li-hong FAN2,4, Hong-yan TIAN2,4, Ai-qun MA2,5, Zhi HU2, Jian-hua HUO2, Yong-xiao CAO3 2Department of Cardiology, The First Affiliated Hospital of Xi-an Jiaotong University School of Medicine, Xi-an 710061, China; 3Department of Phar- macology, Xi’an Jiaotong University School of Medicine, Xi-an 710061, China Key words Abstract ATP-sensitive potassium channel; obesity- Aim: To determine whether ATP-sensitive potassium channels are altered in hypertension; electrophysiology; aorta; VSMC from arotas and mesenteric arteries of obese rat, and their association with mesenteric artery obesity-triggered increase in blood pressure. Methods: Obesity was induced 1 Project supported by the National Natural by 24 weeks of high-fat diet feeding in male Sprague–Dawley rats. Control rats Science Foundation of China (No 30370677). were fed with standard laboratory rat chow. Blood pressure and body weight of 4 These two authors contributed equally to this work. these rats were measured every 4 weeks. At the end of 24 weeks, KATP channel- 5 Correspondence to Prof Ai-qun MA. mediated relaxation responses in the aortas and mesenteric arteries, KATP channel Phn/Fax 86-29-8526-1809. current, and gene expression were examined, respectively. Results: Blood pres- E-mail [email protected] sure and body weight were increased in rats fed with high-fat diet. KATP channel- Received 2007-12-26 mediated relaxation responses, currents, and KATP expression in VSMC of both Accepted 2008-04-22 aortas and mesenteric arteries were inhibited in these rats.
    [Show full text]
  • Synthesis and Vasorelaxant Effect of 9-Aryl-1, 8-Acridinediones As
    Iranian Journal of Pharmaceutical Research (2012), 11 (1): 229-233 Copyright © 2012 by School of Pharmacy Received: January 2010 Shaheed Beheshti University of Medical Sciences and Health Services Accepted: July 2010 Original Article Synthesis and Vasorelaxant Effect of 9-aryl-1,8-acridinediones as Potassium Channel Openers in Isolated Rat Aorta Mohsen Imenshahidia, Farzin Hadizadeha,b*, Asieh Firoozeh-Moghadama, Mahmoud Seifia, Atefeh Shirinbaka and Mohammad Bagher Gharedaghia aPharmacy Faculty, Mashhad University of Medical Sciences, Mashhad, Iran. bBiotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Abstract ATP-sensitive potassium (KATP) channel openers have a relaxation effect due to the lower cellular membrane potential and inhibit calcium influx. There has been considerable interest in exploring KATP channel openers in the treatment of various diseases such as cardiovascular, cerebrovascular, and urinary system disease and premature labor. The purpose of this study was to synthesize 3,3,6,6-tetramethy l-9-aryl-octahydro-1,8-acridindiones and investigate their effects on vascular potassium channels and mechanism of induced relaxations on phenylephrine- induced contractile responses in isolated rings of rat aortic smooth muscle. In this study, four new derivatives of 3,3,6,6-tetramethy l-9-aryl-octahydro-1,8-acridindione [2a-d] were synthesized by the reaction of 5, 5-dimethyl-1,3-cyclohexanedione with an aromatic aldehyde, 2-alkylthio-1-(4-fluorobenzyl)-5-formylimidazole or 3-substituted benzaldehyde, in the presence of ammonia in methanol. Their effects on vascular potassium channels and mechanism of induced relaxations on phenylephrine-induced contractile responses in isolated rat aorta were investigated. Minoxidil was used as a standard potassium channel opener and Glibenclamide was used as a standard potassium channel blocker.
    [Show full text]